Wexford Capital LP Ionis Pharmaceuticals Inc Transaction History

Wexford Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $828,482 - $1 Million	-15,385 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $295,300 - $360,750	5,000 Added 48.15%	15,385 $922,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $248,360 - $344,560	-4,000 Reduced 27.81%	10,385 $667,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $962,879 - $1.48 Million	-18,195 Reduced 55.85%	14,385 $1.17 Million
Q2 2018 Aug 13, 2018	BUY	$40.53 - $50.7 $1.01 Million - $1.27 Million	25,000 Added 329.82%	32,580 $1.36 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $334,126 - $417,279	7,580 New	7,580 $334,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.